MARSHALL WACE, LLP - AXOVANT GENE THERAPIES LTD ownership

AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 2 filers reported holding AXOVANT GENE THERAPIES LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q1 2019$544,000409,7380.00%
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q1 2019.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders